In the long human story of reckoning with extinction, Colossal Biosciences now finds itself humbled by the very complexity it sought to conquer. The Dallas-based company, which once promised living woolly mammoths by 2028, has pushed that horizon to the early 2030s after discovering that resurrection demands editing more than 150 genes — not the 60 originally envisioned. It is a delay that speaks less to failure than to the sobering distance between ambition and the intricate grammar of life itself.
Woolly mammoth revival pushed to early 2030s as gene-editing proves more complex
More than 150 genes to edit, not 60—the mammoth proved far more complex
Mark
So they said 2028, and now it's early 2030s. That's a significant slip. What changed?
Mimi
They discovered the genetic editing work is far more complex than they thought. Instead of editing 60 genes, they need to edit over 150. That's more than double the original estimate.
Luke
But how confident are we in that 150 number? Is that their current best estimate, or is it still moving?
Mimi
It's what they're reporting now based on their research into the genetic code. They've identified genes controlling ear size, coat thickness, body structure—it's spread across many more places than they anticipated.
Mark
Why did they get it so wrong the first time?
Mimi
Their previous de-extinction project, the dire wolf in 2025, apparently required fewer genetic edits. That may have made them think the mammoth would be similar. It wasn't.
Luke
So the dire wolf success actually misled them about how hard the mammoth would be?
Mimi
It appears so. Different extinct species have different genetic distances from their living relatives.
Mark
They're using AI to solve this. How does that actually work?
Mimi
The AI helps parse genetic data, identify which genes control which traits, and model how edits will affect development. It's computational heavy lifting on top of the biological work.
Luke
And they've already tested some of this—the woolly mice with mammoth hair genes?
Mimi
Right. 38 mice created with mammoth genetic coding. It shows the approach can work in living animals, at least at that scale.
Mark
What does this mean for their other projects—the dodo, the Tasmanian tiger?
Mimi
If the mammoth is taking longer than expected, those probably will too. Each species has its own genetic complexity to untangle.
El Pulso
- A threefold increase in required genetic edits — from 60 to over 150 genes — has upended Colossal's original 2028 deadline and exposed how deeply the company underestimated the mammoth's genetic complexity.
- The 2025 success of their dire wolf revival may have bred a quiet overconfidence, masking how much harder it would be to reconstruct the mammoth's distinctive coat, ears, and body proportions from modern elephant DNA.
- Colossal is now deploying AI alongside CRISPR to map which genes govern which traits and model how edits ripple through a developing organism — turning a biological challenge into a computational one as well.
- A family of 38 woolly mice engineered with mammoth-like shaggy hair offers early proof that the editing strategy can work in living animals, keeping the project credible even as the timeline stretches.
- With dodo, Tasmanian tiger, and moa revivals running in parallel, the mammoth delay signals that every de-extinction promise on Colossal's roster may be subject to the same reckoning with genetic reality.
In the long human story of reckoning with extinction, Colossal Biosciences now finds itself humbled by the very complexity it sought to conquer. The Dallas-based company, which once promised living woolly mammoths by 2028, has pushed that horizon to the early 2030s after discovering that resurrection demands editing more than 150 genes — not the 60 originally envisioned. It is a delay that speaks less to failure than to the sobering distance between ambition and the intricate grammar of life itself.
When Colossal Biosciences announced in 2024 that woolly mammoths would walk again by 2028, the promise felt almost within reach. The plan was elegant in outline: extract DNA from a Siberian mammoth specimen, edit roughly 60 genes in an elephant cell nucleus, and let biology do the rest. Two years on, that outline has been redrawn. The company now targets the early 2030s — somewhere between 2030 and 2036, according to CEO Ben Lamm — after discovering that the true number of required genetic edits exceeds 150, a threefold increase that reframes the entire undertaking.
The revision is not merely a scheduling inconvenience. It reveals how much genetic distance separates a living Asian elephant from a woolly mammoth. The traits that defined the mammoth — its shaggy coat, its ear shape, its body proportions — are encoded across far more genes than early analysis suggested, each requiring precise identification and editing. Colossal's 2025 success in producing a dire wolf, which demanded fewer interventions, may have quietly inflated confidence about how tractable the mammoth work would be.
To manage the expanded task, the company is leaning on artificial intelligence alongside CRISPR technology, using AI to parse genetic data, identify trait-controlling genes, and model how edits will cascade through a developing organism. Progress is real: a family of 38 woolly mice carrying mammoth-like hair genes demonstrates that at least part of the strategy works in living animals.
Colossal is pursuing the mammoth alongside de-extinction projects for the dodo, Tasmanian tiger, and moa — each presenting its own genetic puzzle under the same AI-and-CRISPR toolkit. The company's willingness to publicly acknowledge the delay, rather than quietly shifting goalposts, suggests a more honest accounting of what genetic resurrection actually demands. The early 2030s remain within sight, but they are no longer the near-certain milestone they once appeared to be.
When Colossal Biosciences announced in 2024 that woolly mammoths would be born in their laboratories by 2028, the timeline felt almost plausible—a near-term miracle of genetic engineering and artificial intelligence working in concert. The Dallas-based company had already mapped the path: take DNA from a frozen mammoth specimen recovered from Siberia in 2018, edit roughly 60 genes in an elephant cell nucleus to transform it into a mammoth nucleus, and let the biology unfold. Two years later, that promise has shifted. The company now expects the first woolly mammoths in the early 2030s, a delay that reflects a humbling discovery about the actual complexity of bringing an extinct species back to life.
The problem, as it turns out, is genetic arithmetic. Colossal's researchers found that reviving the woolly mammoth requires editing not 60 genes but more than 150—a threefold increase in the number of genetic modifications needed to convert modern elephant DNA into something that would produce a living, breathing mammoth. Ben Lamm, the company's chief executive, told TIME that the timeline now sits somewhere between 2030 and 2036, with no fixed date yet announced. The shift is significant not because it pushes the project into the distant future, but because it exposes how much the company underestimated the genetic distance between what exists and what they are trying to resurrect.
The complexity proved steeper than Colossal's previous de-extinction work suggested it would be. In 2025, the company successfully produced a dire wolf—a project that apparently required fewer genetic interventions than the mammoth revival now demands. That earlier success may have created a false sense of how straightforward the mammoth work would be. The genetic code governing a woolly mammoth's distinctive features—the size and shape of its ears, its thick shaggy coat, its body proportions—turned out to be distributed across far more genes than initial analysis indicated. Each one must be identified, understood, and edited with precision.
To manage this expanded task, Colossal is leaning heavily on artificial intelligence alongside CRISPR gene-editing technology. The AI is being deployed to parse through genetic data, identify which genes control which traits, and model how edits will cascade through a living organism's development. It is a computational problem as much as a biological one. The company has already demonstrated some success with this approach: they created a family of 38 woolly mice carrying genetic code for mammoth-like shaggy hair, proof that at least some of the editing strategy works in living animals.
Colossal is not putting all its effort into the mammoth. The company is simultaneously pursuing de-extinction of the dodo bird, the Tasmanian tiger, and the moa, an emu-like creature from New Zealand. Each project uses the same toolkit—AI and CRISPR—but each presents its own genetic puzzle. The mammoth delay suggests that every one of these revivals may take longer than initially promised. The company's willingness to publicly acknowledge the timeline slip, rather than quietly extending deadlines, suggests a shift toward more realistic communication about what genetic resurrection actually requires. The early 2030s target is still within reach, but it is no longer the near-certain milestone it appeared to be two years ago.
Citas Notables
We are thinking it will be in the early 2030s. We don't have a hard date. Not 2036, but not 2030 either.— Ben Lamm, CEO of Colossal Biosciences, to TIME
Quieres la nota completa?
Lee el original en New York Post ↗